Advertisement Supported by Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits
Table of Contents: How quickly does semaglutide GLP-1 start suppressing appetite
Most patients in the trial were able to have a 5% weight loss while people who received 10 mg or 15 mg doses demonstrated 20% reduction in body weight
They also have protective effects on the liver in cases of alcohol-related liver disease, MASLD, and NASH, with a relative risk of 2.48 for resolving NASH
Cognitive function was calculated as a composite score of 18 different tests of memory, comprehension, language and spatial orientation (ADAS EXEC z score)
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity